NO980656D0 - Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreft - Google Patents
Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreftInfo
- Publication number
- NO980656D0 NO980656D0 NO980656A NO980656A NO980656D0 NO 980656 D0 NO980656 D0 NO 980656D0 NO 980656 A NO980656 A NO 980656A NO 980656 A NO980656 A NO 980656A NO 980656 D0 NO980656 D0 NO 980656D0
- Authority
- NO
- Norway
- Prior art keywords
- human antibody
- reshaped human
- reshaped
- preparing
- treat cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fireproofing Substances (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Dental Preparations (AREA)
- Paper (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898926045A GB8926045D0 (en) | 1989-11-17 | 1989-11-17 | Specific binding agents |
| GB909019552A GB9019552D0 (en) | 1990-09-07 | 1990-09-07 | Specific binding agents |
| PCT/GB1990/001755 WO1991007500A1 (en) | 1989-11-17 | 1990-11-14 | Specific binding agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980656L NO980656L (no) | 1992-05-15 |
| NO980656D0 true NO980656D0 (no) | 1998-02-16 |
Family
ID=26296218
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921941A NO303066B1 (no) | 1989-11-17 | 1992-05-15 | Gjenformet menneskeantistoff med spesifisitet for human placental alkalisk fosfatase eller fragment derav |
| NO980656A NO980656D0 (no) | 1989-11-17 | 1998-02-16 | Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreft |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921941A NO303066B1 (no) | 1989-11-17 | 1992-05-15 | Gjenformet menneskeantistoff med spesifisitet for human placental alkalisk fosfatase eller fragment derav |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0429242B1 (no) |
| JP (1) | JPH05501357A (no) |
| KR (2) | KR970007783B1 (no) |
| AT (1) | ATE123815T1 (no) |
| AU (1) | AU652923B2 (no) |
| BG (1) | BG60687B1 (no) |
| CA (1) | CA2066670A1 (no) |
| DE (1) | DE69020112T2 (no) |
| DK (1) | DK0429242T3 (no) |
| ES (1) | ES2075169T3 (no) |
| FI (1) | FI922220A (no) |
| GR (1) | GR3017407T3 (no) |
| HU (1) | HUT64600A (no) |
| NO (2) | NO303066B1 (no) |
| RO (1) | RO110262B1 (no) |
| WO (1) | WO1991007500A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019553D0 (en) * | 1990-09-07 | 1990-10-24 | Unilever Plc | Specific binding agents |
| WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
| GB0510790D0 (en) | 2005-05-26 | 2005-06-29 | Syngenta Crop Protection Ag | Anti-CD16 binding molecules |
| JP5297742B2 (ja) * | 2008-09-26 | 2013-09-25 | 株式会社青木科学研究所 | 金型用粉体含有油性潤滑剤、これを用いた静電塗布方法、及び静電塗布装置 |
| PT3383920T (pt) | 2015-11-30 | 2024-04-15 | Univ California | Entrega de carga útil específica para tumores e ativação imune utilizando um anticorpo humano que tem como alvo um antigénio altamente específico da superfície das células tumorais |
| EP3806894A4 (en) * | 2018-06-12 | 2022-06-08 | Promab Biotechnologies, Inc. | PLAP-CAR EFFECTIVE CELLS |
| CA3209579A1 (en) | 2021-01-27 | 2022-08-04 | Innovent Biologics (Suzhou) Co., Ltd. | Single-domain antibody against cd16a and use thereof |
| WO2023064928A2 (en) * | 2021-10-14 | 2023-04-20 | Arsenal Biosciences, Inc. | Immune cells having co-expressed shrnas and logic gate systems |
| CN114014933B (zh) * | 2021-11-17 | 2023-05-02 | 福州迈新生物技术开发有限公司 | 抗plap蛋白单克隆抗体、细胞系及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
-
1990
- 1990-11-14 KR KR1019970700530A patent/KR970007783B1/ko not_active IP Right Cessation
- 1990-11-14 WO PCT/GB1990/001755 patent/WO1991007500A1/en active IP Right Grant
- 1990-11-14 DK DK90312407.1T patent/DK0429242T3/da active
- 1990-11-14 EP EP90312407A patent/EP0429242B1/en not_active Expired - Lifetime
- 1990-11-14 ES ES90312407T patent/ES2075169T3/es not_active Expired - Lifetime
- 1990-11-14 JP JP2515801A patent/JPH05501357A/ja active Pending
- 1990-11-14 AU AU67369/90A patent/AU652923B2/en not_active Ceased
- 1990-11-14 RO RO92-200678A patent/RO110262B1/ro unknown
- 1990-11-14 DE DE69020112T patent/DE69020112T2/de not_active Expired - Fee Related
- 1990-11-14 KR KR1019920701176A patent/KR970007782B1/ko not_active IP Right Cessation
- 1990-11-14 HU HU9201619A patent/HUT64600A/hu unknown
- 1990-11-14 AT AT90312407T patent/ATE123815T1/de not_active IP Right Cessation
- 1990-11-14 CA CA002066670A patent/CA2066670A1/en not_active Abandoned
-
1992
- 1992-05-15 BG BG96346A patent/BG60687B1/bg unknown
- 1992-05-15 FI FI922220A patent/FI922220A/fi unknown
- 1992-05-15 NO NO921941A patent/NO303066B1/no unknown
-
1995
- 1995-09-13 GR GR950402540T patent/GR3017407T3/el unknown
-
1998
- 1998-02-16 NO NO980656A patent/NO980656D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05501357A (ja) | 1993-03-18 |
| DK0429242T3 (da) | 1995-10-16 |
| WO1991007500A1 (en) | 1991-05-30 |
| NO303066B1 (no) | 1998-05-25 |
| EP0429242A2 (en) | 1991-05-29 |
| NO980656L (no) | 1992-05-15 |
| BG60687B1 (bg) | 1995-12-29 |
| KR920703837A (ko) | 1992-12-18 |
| NO921941L (no) | 1992-05-15 |
| DE69020112T2 (de) | 1995-11-02 |
| FI922220A0 (fi) | 1992-05-15 |
| CA2066670A1 (en) | 1991-05-18 |
| DE69020112D1 (de) | 1995-07-20 |
| RO110262B1 (ro) | 1995-11-30 |
| HUT64600A (en) | 1994-01-28 |
| AU6736990A (en) | 1991-06-13 |
| GR3017407T3 (en) | 1995-12-31 |
| HU9201619D0 (en) | 1992-08-28 |
| EP0429242B1 (en) | 1995-06-14 |
| AU652923B2 (en) | 1994-09-15 |
| BG96346A (bg) | 1993-12-24 |
| ES2075169T3 (es) | 1995-10-01 |
| KR970007782B1 (ko) | 1997-05-16 |
| NO921941D0 (no) | 1992-05-15 |
| FI922220A (fi) | 1992-05-15 |
| ATE123815T1 (de) | 1995-06-15 |
| KR970007783B1 (ko) | 1997-05-16 |
| EP0429242A3 (en) | 1991-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2193129T3 (es) | Ligantes especificos. | |
| NO980656D0 (no) | Analogifremgangsmåte for fremstilling av et gjenformet menneskeantistoff eller et gjenformet menneskeantistoff-fragment til å behandle kreft | |
| NO851384L (no) | Monoklonale antistoffer og hybriddomaceller og fremgangsmaate til fremstilling og anvendelse derav | |
| DK154086C (da) | Monoklonalt antistof, fremstilling deraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaade til diagnose ved anvendelse heraf | |
| JPS6413988A (en) | Hybridoma | |
| MY8600513A (en) | Monoclonal antibody to human helper t cells, method of preparing it, hybird cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositons comprising it | |
| AU545181B2 (en) | Hybridoma for producing monoclonal antibodies | |
| DE3584872D1 (de) | Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag. | |
| DE3582358D1 (de) | Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers. | |
| SE7906273L (sv) | Sett att framstella en gammaglobulinlosning | |
| FI885279A0 (fi) | Menetelmä 2 3-sidoksen tunnistavan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridooma | |
| FR2455896A1 (fr) | Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin | |
| FI945485A (fi) | Monoklonaaliset vasta-aineet ja niiden käyttö | |
| PT99114A (pt) | Processo para a preparacao de anticorpos monoclonais dirigidos contra complexos formados por trombina e inibidores de trombina | |
| ES469406A1 (es) | Procedimientos para metalizacion de placas hechas a base de cemento reforzado con fibra de vidrio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |